Craig C. Estwick
Presidente presso Nexpep Pty Ltd.
Posizioni attive di Craig C. Estwick
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Nexpep Pty Ltd. | Presidente | 01/01/2009 | - |
Storia della carriera di Craig C. Estwick
Precedenti posizioni note di Craig C. Estwick
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Deloitte Consulting Pty Ltd.
 Deloitte Consulting Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte Consulting Pty Ltd. provides cyber security consulting services. The company is based in Sydney, Australia. | Corporate Officer/Principal | - | 01/01/2000 |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - | - |
Formazione di Craig C. Estwick
| The University of Queensland | Graduate Degree |
Statistiche
Distribuzione geografica
| Australia | 4 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 1 |
| Graduate Degree | 1 |
| Chairman | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
| Nexpep Pty Ltd. | |
Deloitte Consulting Pty Ltd.
Deloitte Consulting Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte Consulting Pty Ltd. provides cyber security consulting services. The company is based in Sydney, Australia. | Commercial Services |
- Borsa valori
- Insiders
- Craig C. Estwick
- Esperienza
